...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: Resverlogix Announces Apabetalone Prior to SARS-CoV-2 (COVID-19) Exposure Reduces Viral Infection – Confirms Plans for COVID-19 Clinical Trial

COVID-19 treatments. The 40,000 ft view.....

As of the end of November, there are:

590+ drug development programs in the planning stages
390+ trials that have been reviewed by the FDA
90+ early stage trials testing safety and dosing
300+ late stage trials testing efficacy and safety

Share
New Message
Please login to post a reply